2c6t
From Proteopedia
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
| - | Crystallographic and modelling data, in conjunction with a medicinal | + | Crystallographic and modelling data, in conjunction with a medicinal chemistry template-hopping approach, led to the identification of a series of novel and potent inhibitors of human cyclin-dependent kinase 2 (CDK2), with selectivity over glycogen synthase kinase-3beta (GSK-3beta). One example had a CDK2 IC(50) of 120 nM and showed selectivity over GSK-3beta of 167-fold. |
==About this Structure== | ==About this Structure== | ||
| Line 13: | Line 13: | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Protein complex]] | [[Category: Protein complex]] | ||
| - | [[Category: Transferred entry: 2 | + | [[Category: Transferred entry: 2 7.11 1]] |
[[Category: Dokurno, P.]] | [[Category: Dokurno, P.]] | ||
| - | [[Category: Murray, J | + | [[Category: Murray, J B.]] |
| - | [[Category: Richardson, C | + | [[Category: Richardson, C M.]] |
| - | [[Category: Surgenor, A | + | [[Category: Surgenor, A E.]] |
[[Category: DT5]] | [[Category: DT5]] | ||
[[Category: atp-binding]] | [[Category: atp-binding]] | ||
| Line 28: | Line 28: | ||
[[Category: triazolopyrimidine inhibitor]] | [[Category: triazolopyrimidine inhibitor]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:45:30 2008'' |
Revision as of 14:45, 21 February 2008
|
CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
Overview
Crystallographic and modelling data, in conjunction with a medicinal chemistry template-hopping approach, led to the identification of a series of novel and potent inhibitors of human cyclin-dependent kinase 2 (CDK2), with selectivity over glycogen synthase kinase-3beta (GSK-3beta). One example had a CDK2 IC(50) of 120 nM and showed selectivity over GSK-3beta of 167-fold.
About this Structure
2C6T is a Protein complex structure of sequences from Homo sapiens with as ligand. Active as Transferred entry: 2.7.11.1, with EC number 2.7.1.37 Known structural/functional Site: . Full crystallographic information is available from OCA.
Reference
Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: protein structure-guided design and SAR., Richardson CM, Williamson DS, Parratt MJ, Borgognoni J, Cansfield AD, Dokurno P, Francis GL, Howes R, Moore JD, Murray JB, Robertson A, Surgenor AE, Torrance CJ, Bioorg Med Chem Lett. 2006 Mar 1;16(5):1353-7. Epub 2005 Dec 1. PMID:16325401
Page seeded by OCA on Thu Feb 21 16:45:30 2008
Categories: Homo sapiens | Protein complex | Transferred entry: 2 7.11 1 | Dokurno, P. | Murray, J B. | Richardson, C M. | Surgenor, A E. | DT5 | Atp-binding | Cdk2 | Cell cycle | Complex (transferase/cyclin2) | Mitosis | Phosphorylation | Serine/threonine protein kinase | Triazolopyrimidine inhibitor
